<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-1L9EYWOJ</identifier><date>2023</date><creator>Detiček, Andreja</creator><creator>Tršinar, Maja</creator><relation>documents/doc/1/URN_NBN_SI_doc-1L9EYWOJ_001.pdf</relation><relation>documents/doc/1/URN_NBN_SI_doc-1L9EYWOJ_001.txt</relation><format format_type="issue">2</format><format format_type="volume">74</format><format format_type="type">article</format><format format_type="extent">str. 141-150</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">189950467</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-1L9EYWOJ</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antidepresivi</subject><subject language_type_id="slv">klinični primer</subject><subject language_type_id="slv">selektivni zaviralci privzema serotonina</subject><subject language_type_id="slv">serotoninski sindrom</subject><title>Serotoninski sindrom pri zdravljenju z antidepresivi – klinična primera</title><title>Antidepressants induced serotonin syndrome – two clinical cases</title></Record>